The vacuum of clear ?nformat?on around Gunns ?s be?ng f?lled by w?ld speculat?on that sw?ngs between the prospect of a jo?nt venture partner and adm?n?strat?on.
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status